ITGAX and systemic lupus erythematosus: Compared with the healthy donors, the expression of PKM2 was significantly increased in the CD14+ monocytes (Figure 9E), CD11c+ DCs (Figure 9F), and CD19+ B cells (Figure 9G) of the SLE patients.